Sunday 18 October 2026
Export NUVOQ’s income statement to Excel — free account
Holdco Nuvo Group D.G Ltd.
NUVOQ Healthcare Medical Devices
Holdco Nuvo Group D.G Ltd.’s revenue for fiscal 2023 (year ended December 2023) was $176,000.00.
0.00
0.00
NaN
Follow NUVOQ
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
P/E ratio |
+6 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.09 | 0.01 | 0.02 | 0.02 | |
Current Ratio |
0.18 | 0.09 | 0.04 | 0.05 | |
Net Debt/EBITDA |
0.19 | 0.02 | 0.02 | (1.23) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 332.07% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.17) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.07) | 0.51 | 0.07 | 0.46 | |
Capex/Depreciation |
— | — | — | (0.17) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.02) | (0.12) | 0.00 | (0.78) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.12) | 0.00 | (0.78) | |
Cash per Share |
0.01 | 0.01 | 0.00 | 0.03 | |
Shareholders Equity per Share |
(1.29) | (3.32) | 0.00 | (3.74) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(1.29) | (3.32) | 0.00 | (3.74) | |
Free Cash Flow |
(0.15) | (0.48) | (0.34) | (13.99) | |
Working Capital |
(1.05) | (3.11) | (5.18) | (29.37) | |
Capital Expenditures |
— | — | — | (0.04) | |
Net Current Asset Value |
(278.66) | (47.13) | (49.61) | (69.40) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | — | 0.00 | |
| Other line items | |||||
Average Assets |
265.20 | 148.37 | 147.64 | 3.62 | |
Average Common Equity |
(9.96) | (11.10) | (13.82) | (53.10) |
Columns are period end dates